EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

High-Sensitivity Cardiac Troponin Assays: From Implementation to Resource Utilization and Cost Effectiveness

Hong-Kee Lee, Cian P McCarthy, Allan S Jaffe iD, Richard Body iD, Ahmed Alotaibi, Yader Sandoval iD, James L Januzzi iD

The Journal of Applied Laboratory Medicine · 02.05.2025 · 10 (3) · 710-730

DOI: 10.1093/jalm/jfae161 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 05.02.2025. Verfasst von Hong-Kee Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Endeavor Health, Evanston, IL, United States. Hauptthemen laut MEDLINE: Myocardial Infarction, Troponin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Cardiac troponin is the gold-standard biomarker for the evaluation of patients with suspected acute myocardial infarction (MI). Improvements in assay technology have led to high-sensitivity cardiac troponin assays that, when incorporated into accelerated diagnostic pathways, may rapidly diagnose or exclude acute MI more efficiently than conventional troponin assays. Content In this narrative review, we provide practical suggestions for implementing high-sensitivity cardiac troponin assays, review accelerated diagnostic pathways incorporating these assays, and review the impact of these assays on resource utilization and cost-effectiveness in relation to the evaluation of individuals with possible acute MI. Summary An increasing number of hospitals are transitioning to high-sensitivity cardiac troponin assays. This narrative review provides an overview of the potential benefits of this transition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionTroponinHumansCost-Benefit AnalysisBiomarkersSensitivity and SpecificityCost-Effectiveness Analysis

Substanzen

BiomarkersTroponin

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Endeavor Health, Evanston, IL, United States.
  • Department of Pathology, University of Chicago Pritzker School of Medicine, Chicago, IL, United States.
  • Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
  • Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United States.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Department of Emergency Medicine, University of Manchester, Manchester, United Kingdom.

ORCID-Profile: Allan S Jaffe, Richard Body, Yader Sandoval, James L Januzzi

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Lee, H. K., McCarthy, C. P., Jaffe, A. S., Body, R., Alotaibi, A., Sandoval, Y., & Januzzi, J. L. (2025). High-Sensitivity Cardiac Troponin Assays: From Implementation to Resource Utilization and Cost Effectiveness. The Journal of Applied Laboratory Medicine, 10(3), 710-730. https://doi.org/10.1093/jalm/jfae161

Vancouver

Lee HK, McCarthy CP, Jaffe AS, Body R, Alotaibi A, Sandoval Y, et al. High-Sensitivity Cardiac Troponin Assays: From Implementation to Resource Utilization and Cost Effectiveness. The Journal of Applied Laboratory Medicine. 2025;10(3):710-730. doi:10.1093/jalm/jfae161

BibTeX
@article{Lee2025,
  author = {Lee, Hong-Kee and McCarthy, Cian P and Jaffe, Allan S and Body, Richard and Alotaibi, Ahmed and Sandoval, Yader and Januzzi, James L},
  title = {High-Sensitivity Cardiac Troponin Assays: From Implementation to Resource Utilization and Cost Effectiveness},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2025},
  volume = {10},
  number = {3},
  pages = {710--730},
  doi = {10.1093/jalm/jfae161}
}
Kostenlos starten →